Literature DB >> 30507663

Spurious Laboratory Values in Patients With Leukocytosis.

Tony Malek1, Leon Chen.   

Abstract

Physiological derangements such as hypoxemia and hyperkalemia are medical emergencies that warrant prompt interventions to prevent further patient clinical deterioration. However, in patients with myeloproliferative diseases or malignancies that result in extreme leukocytosis, hypoxemia and hyperkalemia demonstrated in laboratory results could be deceiving due to in vitro reactions and may not reflect actual patient condition. Clinicians have to be familiar with these phenomena so as to not cause harm by treating these spurious laboratory values.

Entities:  

Mesh:

Year:  2019        PMID: 30507663      PMCID: PMC7528080          DOI: 10.1097/CNQ.0000000000000236

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  7 in total

Review 1.  Spurious hyperkalaemia.

Authors:  W Stuart A Smellie
Journal:  BMJ       Date:  2007-03-31

2.  Pseudohyperkalaemia or spurious hyperkalaemia.

Authors:  M A Crook
Journal:  Ann Clin Biochem       Date:  2013-03       Impact factor: 2.057

Review 3.  Myeloproliferative disorders.

Authors:  Brian Meier; John H Burton
Journal:  Emerg Med Clin North Am       Date:  2014-06-07       Impact factor: 2.264

Review 4.  Pseudohyperkalemia: A new twist on an old phenomenon.

Authors:  Qing H Meng; Elizabeth A Wagar
Journal:  Crit Rev Clin Lab Sci       Date:  2014-10-16       Impact factor: 6.250

5.  Pseudohypoxaemia in a patient with acute leukaemia.

Authors:  S Charoenratanakul; K Loasuthi
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

6.  Pseudohypoxemia in a patient with chronic lymphocytic leukemia.

Authors:  Samuel Horr; Russell Roberson; John W Hollingsworth
Journal:  Respir Care       Date:  2013-03       Impact factor: 2.258

7.  Pseudohyperkalemia in patients with chronic lymphocytic leukemia.

Authors:  Stephen I Rifkin
Journal:  Int J Nephrol       Date:  2011-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.